DK1252155T3 - Ethanolsolvat af (-)-cis-2-(2-chlorphenyl)-5,7-dihydroxy-8-[4R-(3S-hydroxy-1-methyl)piperidinyl]-4H-1-benzopyran-4-on - Google Patents

Ethanolsolvat af (-)-cis-2-(2-chlorphenyl)-5,7-dihydroxy-8-[4R-(3S-hydroxy-1-methyl)piperidinyl]-4H-1-benzopyran-4-on

Info

Publication number
DK1252155T3
DK1252155T3 DK01902993T DK01902993T DK1252155T3 DK 1252155 T3 DK1252155 T3 DK 1252155T3 DK 01902993 T DK01902993 T DK 01902993T DK 01902993 T DK01902993 T DK 01902993T DK 1252155 T3 DK1252155 T3 DK 1252155T3
Authority
DK
Denmark
Prior art keywords
benzopyran
piperidinyl
chlorophenyl
dihydroxy
cis
Prior art date
Application number
DK01902993T
Other languages
Danish (da)
English (en)
Inventor
Kurt M Kesseler
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK1252155T3 publication Critical patent/DK1252155T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK01902993T 2000-01-18 2001-01-08 Ethanolsolvat af (-)-cis-2-(2-chlorphenyl)-5,7-dihydroxy-8-[4R-(3S-hydroxy-1-methyl)piperidinyl]-4H-1-benzopyran-4-on DK1252155T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48781500A 2000-01-18 2000-01-18
EP01902993A EP1252155B1 (fr) 2000-01-18 2001-01-08 Solvate d'ethanol sous forme (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8- [4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
PCT/US2001/000520 WO2001053294A1 (fr) 2000-01-18 2001-01-08 Solvate d'ethanol sous forme (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one

Publications (1)

Publication Number Publication Date
DK1252155T3 true DK1252155T3 (da) 2005-04-04

Family

ID=23937213

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01902993T DK1252155T3 (da) 2000-01-18 2001-01-08 Ethanolsolvat af (-)-cis-2-(2-chlorphenyl)-5,7-dihydroxy-8-[4R-(3S-hydroxy-1-methyl)piperidinyl]-4H-1-benzopyran-4-on

Country Status (26)

Country Link
EP (1) EP1252155B1 (fr)
JP (1) JP2003520798A (fr)
KR (1) KR100825530B1 (fr)
CN (1) CN1395577A (fr)
AR (1) AR027226A1 (fr)
AT (1) ATE284400T1 (fr)
AU (1) AU2001230869A1 (fr)
BR (1) BR0107724A (fr)
CA (1) CA2397594C (fr)
CZ (1) CZ301235B6 (fr)
DE (1) DE60107652T2 (fr)
DK (1) DK1252155T3 (fr)
EA (1) EA005182B1 (fr)
ES (1) ES2228800T3 (fr)
HU (1) HU225155B1 (fr)
IL (2) IL150643A0 (fr)
MX (1) MXPA02006965A (fr)
NO (1) NO322626B1 (fr)
NZ (1) NZ520281A (fr)
PL (1) PL201690B1 (fr)
PT (1) PT1252155E (fr)
SI (1) SI1252155T1 (fr)
SK (1) SK287216B6 (fr)
TW (1) TWI293072B (fr)
WO (1) WO2001053294A1 (fr)
ZA (1) ZA200205640B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL264950B2 (en) 2016-08-23 2024-01-01 Eisai R&D Man Co Ltd Combined treatments for the treatment of malignant liver cell carcinoma
IL269357B1 (en) 2017-03-16 2024-06-01 Eisai R&D Man Co Ltd A combination of Era inhibitors and a CDK4/6 inhibitor to be used in a method to treat breast cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164232B (fr) * 1986-04-11 1989-02-04 Hoechst India
DE3836676A1 (de) * 1988-10-28 1990-05-03 Hoechst Ag Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
US5284856A (en) * 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
US5908934A (en) * 1996-09-26 1999-06-01 Bristol-Myers Squibb Company Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs

Also Published As

Publication number Publication date
KR100825530B1 (ko) 2008-04-25
SK287216B6 (sk) 2010-03-08
WO2001053294A1 (fr) 2001-07-26
NO20023385D0 (no) 2002-07-12
JP2003520798A (ja) 2003-07-08
ES2228800T3 (es) 2005-04-16
AU2001230869A1 (en) 2001-07-31
NO20023385L (no) 2002-08-27
EA200200776A1 (ru) 2002-12-26
PT1252155E (pt) 2005-04-29
CA2397594C (fr) 2010-03-23
EP1252155B1 (fr) 2004-12-08
EP1252155A1 (fr) 2002-10-30
SK10372002A3 (sk) 2002-12-03
ZA200205640B (en) 2003-11-26
SI1252155T1 (en) 2005-06-30
PL355992A1 (en) 2004-05-31
TWI293072B (en) 2008-02-01
AR027226A1 (es) 2003-03-19
DE60107652T2 (de) 2005-12-22
HU225155B1 (en) 2006-07-28
HUP0204297A2 (hu) 2003-04-28
IL150643A0 (en) 2003-02-12
CA2397594A1 (fr) 2001-07-26
MXPA02006965A (es) 2004-09-06
HUP0204297A3 (en) 2005-04-28
IL150643A (en) 2009-08-03
NZ520281A (en) 2004-04-30
CZ301235B6 (cs) 2009-12-16
ATE284400T1 (de) 2004-12-15
BR0107724A (pt) 2002-10-01
NO322626B1 (no) 2006-11-06
PL201690B1 (pl) 2009-04-30
KR20020069514A (ko) 2002-09-04
CN1395577A (zh) 2003-02-05
CZ20022467A3 (cs) 2002-10-16
EA005182B1 (ru) 2004-12-30
DE60107652D1 (de) 2005-01-13

Similar Documents

Publication Publication Date Title
NO20023777L (no) Rorformet setteverktoy
DK1515969T3 (da) Spiroindolinpiperidinderivater
DE60114145D1 (de) Fulvestrant formulierung
CY1104912T1 (el) Υποκατεστημενα πυραζολια
NO20032596D0 (no) Heterosykliske etersubstituerte imidazokinoliner
ATE333445T1 (de) Pyrazolderivate
DK1360184T3 (da) Piperidinderivater som neurokinin-1-antagonister
NO20032315D0 (no) 4-(bifenylkarbonylamino)piperidinderivater som MTP- inhibitorer
DE60124942D1 (de) Bohrlochkern-bohrvorrichtung
DE602004026333D1 (de) NEUE KRISTALLINE FORMEN VON ä2-Ä1-(3,5-BISTRIFLUORMETHYLBENZYL)-5-PYRIDIN-4-YL-1H-Ä1,2,3ÜÜTRIAZOL-4-YLÜ-PYRIDIN-3-YLü-(2-CHLORPHENYL)METHANON
DE1134750T1 (de) Monolithische isolierende Durchführung
DE50103035D1 (de) Substituierte 1-aminobutan-3-ol-derivate
NO20022985L (no) Substituerte aminometyl-fenyl-cykloheksanderivater
DK1252155T3 (da) Ethanolsolvat af (-)-cis-2-(2-chlorphenyl)-5,7-dihydroxy-8-[4R-(3S-hydroxy-1-methyl)piperidinyl]-4H-1-benzopyran-4-on
DK1259507T3 (da) Pseudopolymorf af (-)-cis-2-(2-chlorphenyl)-5,7-dihydroxy-8[4R-(3S-hydroxy-1-methyl)piperidinyl]-4H-1-benzopyran-4-on, hydrochlorid
DK1440067T3 (da) N-formyl-derivater af paroxetin
DE60139781D1 (de) 4-substituierte piperidinverbindung
DE50112454D1 (de) Substituierte 5-amino-1-penten-3-ol-derivate
ITMI20001792A0 (it) Struttura di rubinetto temporizzato
NO20013294D0 (no) Dusjskillevegg
ITAN20030018A1 (it) Mezzi di fissaggio dielettrici di una resistenza
NO20013624L (no) Motstandskontrollert offeranode
FI4813U1 (fi) Seinäkesäilytin
EE200000444A (et) Ruunharmonisaator
FI4833U1 (fi) Huuhtelulaite